Facebook
Twitter
LinkedIn
ForwardPulse - From Molly to Medicine: MDMA's Trip to Psychedelic-Assisted Therapy - November 18, 2020
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications. Pharmacists will gain knowledge of a current clinical controversy and become aware of best medication practices.
Target Audience
Pharmacists at UPMC, Pharmacy Faculty at PittPharmacy, Pharmacy Residents, Pharmacy Students
Learning Objectives
Review the history of MDMA and its use in clinical psychiatry
Summarize the current evidence for the clinical use of MDMA for post-traumatic stress disorder
Describe the opportunities and challenges with MDMA-assisted therapy
Discuss the potential role of pharmacy in MDMA-assisted therapy
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications. Pharmacists will gain knowledge of a current clinical controversy and become aware of best medication practices.
Tuyen Nguyen, PharmD, MPH
PGY1 Pharmacy Resident
UPMC Western Psychiatric Hospital
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.